Oramed Pharmaceuticals : 13D-Nadav Kidron -March 26, 2024 at 04:30 am EDT
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED...
Source: marketscreener.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Appropriate Box. Real-time updates on events, politics, business and more.